Fair Pricing for Prescription Drugs Act
Latest action · May 25, 2010 Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Progress
Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.
- IntroducedMay 25, 2010
- Passed SenateNot reached
- Passed HouseNot reached
- To the PresidentNot reached
- Became lawNot reached
Summary
Fair Pricing for Prescription Drugs Act - Pharmaceutical Market Access and Drug Safety Act of 2010 - Amends the Federal Food, Drug, and Cosmetic Act (FFDCA) to revise provisions governing the importation of prescription drugs. Waives the limitation on importation of prescription drugs that have been exported from the United States.
Prohibits the importation of a qualifying drug unless such drug is imported by: (1) a registered importer; or (2) an individual for personal use.
Establishes registration conditions for importers and exporters. Requires the Secretary of Health and Human Services (HHS) to inspect places of business, verify chains of custody, inspect facilities, and determine compliance with registration conditions.
Sets forth provisions governing the importation of qualifying drugs that are different from U.S. label drugs, including standards for judging such differences.
Prohibits manufacturers from: (1) discriminating against registered exporters or importers; (2) causing there to be a difference in a prescription drug distributed in the United States and one distributed in a permitted country; (3) engaging in actions to restrict, prohibit, or delay the importation of a qualifying drug; or (4) engaging in any action that the Federal Trade Commission (FTC) determines discriminates against a person that engages or attempts to engage in the importation of a qualifying drug.
States that the resale in the United States of prescription drugs that were properly sold abroad is not patent infringement.
Requires the Secretary to educate consumers regarding prescription drug importation.
Sets forth provisions governing the sale of prescription drugs through an Internet site. Includes the dispensing or selling of a prescription drug in violation of this Act as a prohibited act under FFDCA.
Prohibits the introduction of restricted transactions with unregistered foreign pharmacies into a payment system or the completion of such transactions using a payment system.
Amends part D (Voluntary Prescription Drug Benefit Program) of title XVIII (Medicare) of the Social Security Act to direct the Secretary to negotiate with pharmaceutical manufacturers the prices that may be charged to Medicare part D prescription drug plan (PDP) sponsors and MedicareAdvantage (MA) organizations for covered part D drugs for part D eligible individuals who are enrolled under a PDP or an MA-Prescription Drug plan.
Cosponsors
Members who signed on, in the order they did.
Committees 1
Where it was sent and what each committee and subcommittee did with it, in order.
| Chamber | Committee | What it did |
|---|---|---|
| Senate | Health, Education, Labor, and Pensions Committee | Referred May 25, 2010 |
Actions 3
Everything that happened, newest first.
- May 25, 2010Introduced in Senate
- May 25, 2010Sponsor introductory remarks on measure. (CR S4218-4219)
- May 25, 2010Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
In the Congressional Record 1
Days the Record’s own index lists this bill, newest first, with the pages and the members it names. Pages starting H are the House, S the Senate, E Extensions of Remarks.
| Where | In the Record | Members | Date |
|---|---|---|---|
| Senate | Debate and remarks S4218 | Russell D. Feingold D-WI | May 25, 2010 |
Related bills 4
Companion bills and other measures the record links to this one.
| Bill | Title | Relationship | Latest action |
|---|---|---|---|
| S 525 | Pharmaceutical Market Access and Drug Safety Act of 2009 | Related bill | Mar 5, 2009 |
| S 1232 | Pharmaceutical Market Access and Drug Safety Act of 2009 | Related bill | Jun 11, 2009 |
| HR 1298 | Pharmaceutical Market Access and Drug Safety Act of 2009 | Related bill | Mar 5, 2009 |
| S 3413 | Medicare Prescription Drug Price Negotiation Act of 2010 | Related bill | May 25, 2010 |
Titles 3
Every title it has carried, official and short, at each stage.
- Official Title as Introduced
- A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to the importation of prescription drugs and to amend part D of title XVIII of the Social Security Act to require the Secretary of Health and Human Services to negotiate covered part D drug prices on behalf of Medicare beneficiaries.
- Short Titles as Introduced
- Fair Pricing for Prescription Drugs Act
- Short Titles as Introduced for portions of this bill
- Pharmaceutical Market Access and Drug Safety Act of 2010
Subjects
Assigned by the Library of Congress. Policy area: Health.
- Asia
- Australia
- Business records
- Canada
- Civil actions and liability
- Consumer affairs
- Drug safety, medical device, and laboratory regulation
- Europe
- European Union
- Fraud offenses and financial crimes
- Government information and archives
- Health
- Health care costs and insurance
- Health care coverage and access
- Inflation and prices
- Internet and video services
- Internet, web applications, social media
- Japan
- Licensing and registrations
- Medicare
- New Zealand
- Oceania
- Prescription drugs
- Retail and wholesale trades
- Switzerland
- Trade restrictions
- User charges and fees
Text 1
Each version as it was printed, newest first.
- May 25, 2010Introduced in Senate
Support LegiList
This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.
Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.